Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI)

Completed

• Conditions: Infection, Mycobacterium Avium-Intracellulare

• Registration Number: NCT00652067
• Lead Sponsor: Yale University

Brief Summary

This protocol is an single patient IND to provide clofazamine to treat one patient who has MAI and is resistant to or can not tolerate standard of care. The drug is not otherwise available.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-05
• Primary Completion: 2007-05
• Study Completion: 2007-05
• Status Verified: 2008-03
• Study First Submitted: 2008-03-31
• Study First Submitted QC: 2008-04-02
• Last Update Submitted: 2008-04-02
• Study First Posted: 2008-04-03
• Last Update Posted: 2008-04-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 1

Inclusion Criteria

• Treatment of one patient with MAI

Exclusion Criteria

• No other patients will be treated

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified